In this context, the study conducted by Wu et al. [6] has verified DLX6-AS1's role in promoting the progression of non-small cell lung cancer (NSCLC) through the regulation of the miR-16/BMI1 pathway. This evidence concerns the gene DLX6 and non-small cell lung carcinoma.